Interferon gamma release assay tests are associated with persistence and completion of latent tuberculosis infection treatment in the United States: Evidence from commercial insurance data

BACKGROUND: Risk-targeted testing and treatment of latent tuberculosis infection (LTBI) is a critical component of the United States’ (US) tuberculosis (TB) elimination strategy, but relatively low treatment completion rates remain a challenge. Both treatment persistence and completion may be facili...

Descripción completa

Detalles Bibliográficos
Autores principales: Stockbridge, Erica L., Loethen, Abiah D., Annan, Esther, Miller, Thaddeus L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714216/
https://www.ncbi.nlm.nih.gov/pubmed/33270737
http://dx.doi.org/10.1371/journal.pone.0243102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714216/
https://www.ncbi.nlm.nih.gov/pubmed/33270737
http://dx.doi.org/10.1371/journal.pone.0243102

Ejemplares similares